XJNGF Financial Statements & Analysis
Complete financial statements for XJNGF including income statement, balance sheet, and cash flow statement. Analyze XJNGF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
25.1% ↑
Net Income
45.3% ↑
Gross Margin
-2.8% ↓
Operating Margin
33.8% ↑
Balance Sheet
Current Ratio
-4.7% ↓
Debt to Equity
-18.8% ↑
Asset Turnover
16.5% ↑
Cash Flow
Operating Cash Flow
29.4% ↑
Net Cash Flow
72.9% ↑
Free Cash Flow
34.5% ↑
Cash Flow to Debt
41.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 56.70B | 70.90B | 25.1% | |
| Gross Profit | 7.82B | 9.50B | 21.5% | |
| Operating Income | 2.17B | 3.63B | 67.4% | |
| Net Income | 1.86B | 2.70B | 45.3% | |
| EPS | 0.42 | 0.62 | 47.6% | |
| EBITDA | 6.70B | 7.62B | 13.8% | |
| Gross Margin | 13.80% | 13.41% | 2.8% | |
| Operating Margin | 3.82% | 5.12% | 33.8% | |
| Net Income Margin | 3.28% | 3.81% | 16.2% | |
| R&D Expenses | 2.48B | 2.08B | 15.9% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 70.90B | 56.70B | 50.46B | — | — |
| Gross Profit | 9.50B | 7.82B | 8.65B | — | — |
| Operating Income | 3.63B | 2.17B | 2.60B | — | — |
| Net Income | 2.70B | 1.86B | 1.33B | — | — |
| EPS | 0.62 | 0.42 | 0.31 | — | — |
| EBITDA | 7.62B | 6.70B | 6.69B | — | — |
| Gross Margin | 13.41% | 13.80% | 17.14% | — | — |
| Operating Margin | 5.12% | 3.82% | 5.15% | — | — |
| Net Income Margin | 3.81% | 3.28% | 2.64% | — | — |
| R&D Expenses | 2.08B | 2.48B | 1.89B | — | — |
Financial Metrics
Want to dive deeper into XJNGF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics